Orphazyme A/S
ORPH
ORPH was delisted on the 30th of March, 2022.
5 hedge funds and large institutions have $1.84M invested in Orphazyme A/S in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 2 reducing their positions, and 13 closing their positions.
69% less funds holding
Funds holding: 16 → 5 (-11)
85% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 13
95% less capital invested
Capital invested by funds: $37.9M → $1.84M (-$36.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$57.9K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$23.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IM
Islet Management
New York
|
-$14M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$5.33M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$5.06M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.07M |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.81M |
ORPH Hedge Fund Activity: Q4 2020 in Review
5 of the 5,675 institutional investors tracked by Wall St. Rank reported a position in Orphazyme A/S (ORPH) for Q4 2020, worth a combined $1.84M — down 95% from $37.9M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of ORPH and 2 opened new positions — a net loss of 11 holders — while 2 trimmed existing stakes and 0 added.
The largest buyer was Osaic Holdings, opening a new position worth an estimated $57.9K. The largest seller was Islet Management, exiting entirely with an estimated $14M sold.
- 5 institutional investors held Orphazyme A/S (ORPH) as of Q4 2020, down from 16 in Q3 2020.
- Funds reported $1.84M of Orphazyme A/S stock for Q4 2020, down 95% quarter-over-quarter.
- 2 funds opened new Orphazyme A/S positions in Q4 2020 and 13 closed out, a net change of -11 holders.
- The largest Orphazyme A/S buyer in Q4 2020 was Osaic Holdings, an estimated $57.9K added.
- The largest Orphazyme A/S seller in Q4 2020 was Islet Management, an estimated $14M sold.
Based on aggregated 13F filings for Q4 2020.